Hennemann, A. et al. 2022. Efficacy of pembrolizumab in a patient with xeroderma pigmentosum variant and advanced cutaneous squamous-cell carcinoma. Acta Oncologica. 61, 9 (Sep. 2022), 1140–1142. DOI:https://doi.org/10.1080/0284186X.2022.2109425.